Introduction

Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care.

Key Features

• - Overcomes the blood-brain barrier using advanced delivery methods.
• - Improves drug penetration and specificity with nano and polymer-based systems
• - Explores new therapies through immunotherapy, gene therapy, and personalised medicine.
• - Builds preclinical models and identifies biomarkers to support clinical success.
• - Designs regulatory-aligned clinical trial strategies for faster translation.

Target Readership:

Researchers, clinicians, pharma developers, and graduate students in neuro-oncology, molecular pharmacology, and oncology-focused biotech.